Researchers have found that when triclosan is combined with an antibiotic called tobramycin, it kills cells that protect cystic fibrosis bacteria by up to 99.9 percent

A recent study has revealed for the first time the potential for simple, easily accessible new methods of predicting on a computer how the compounds will behave

The authors of a new report illustrate how a magnetic nanoparticle assembly approach is used to increase throughput dramatically while reducing costs

A multi-institutional project to understand one of the major targets of human drug design has produced new insights into how structural communication works in a cell component called a G protein-coupled receptor

Early lab-based tests of a recently developed drug were successful in targeting resistant breast cancers and indicated minimal side effects

Newly discovered antibiotic binds to ribosome, disrupts protein synthesis

Discovery opens opportunities for developing new medications with regulated action and fewer side effects

BioIVT now offers unique and proprietary bioengineered micro-liver platforms for use in environmental testing, preventive care, and product development in the pharmaceutical and biopharmaceutical, diagnostic, cosmetics, and chemical industries

Since the start of the 2017-18 flu season in October, the Centers for Disease Control and Prevention has reported over 65,735 positive tests for the virus in the U.S., resulting in hundreds of deaths

The procedure centers on making droplets, which are a mixture of two or more immiscible, or unmixable, liquids—in this case, oil, water, and alcohol